Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine

Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine

Submitted by admin on May 8, 2019 - 5:39pm
Source: 
Pharmafile
News Tags: 
Eli Lilly
migraines
clinical trials
Emgality
Headline: 
Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine
snippet: 

Eli Lilly has announced positive results from the Phase 3 EVOLVE-1 and EVOLVE-2 trials looking into Emgality (galcanezumab-gnlm) for the treatment of episodic migraine.

Do Not Allow Advertisers to Use My Personal information